Apr 1, 2020 - Health

FDA wants heartburn drug pulled from market

A blue box of Zantac on the shelf of a store.
Zantac is the most common brand of ranitidine. Photo: Yichuan Cao/NurPhoto via Getty Images

The Food and Drug Administration is asking all makers of ranitidine, a heartburn drug most commonly known by the brand name Zantac, to pull all forms of the medicine from the market.

The bottom line: Don't take any versions of this drug, which has been linked to cancer-causing contaminants.

Go deeper